Home/Filings/4/0001628280-20-014320
4//SEC Filing

Bridger Gary 4

Accession 0001628280-20-014320

CIK 0001501697other

Filed

Oct 5, 8:00 PM ET

Accepted

Oct 6, 7:36 AM ET

Size

5.6 KB

Accession

0001628280-20-014320

Insider Transaction Report

Form 4
Period: 2020-10-05
Bridger Gary
Director
Transactions
  • Award

    Stock Option (right to buy)

    2020-10-05+30,00030,000 total
    Exercise: $7.33Exp: 2030-10-04Common Stock (30,000 underlying)
Footnotes (1)
  • [F1]33.3333% of the shares subject to the option shall vest on October 5, 2021, with the remainder vesting in equal monthly installments of 2.7777% of the shares subject to the option until the 36-month anniversary of the date of the grant, subject to the Reporting Person's continued services as a director through each applicable vesting date.

Issuer

X4 Pharmaceuticals, Inc

CIK 0001501697

Entity typeother

Related Parties

1
  • filerCIK 0001600049

Filing Metadata

Form type
4
Filed
Oct 5, 8:00 PM ET
Accepted
Oct 6, 7:36 AM ET
Size
5.6 KB